Educational information only. This site does not provide medical advice. Read full disclaimer
    PepTracker Pro
    Open the App
    Research-only content. This page is for educational purposes and does not constitute medical advice. Read full disclaimer →

    LIPO-C

    Low Evidence

    A lipotropic injection blend containing methionine, inositol, choline, and other compounds to support fat metabolism.

    AliasesLipotropic injection+2 more
    EvidenceLow Evidence
    Last Updated 2026-05-27
    Reading Time 2 min

    What It Is

    LIPO-C (lipotropic compound injection) is not a peptide but a combination injection containing methionine, inositol, choline, and often B-vitamins (cyanocobalamin/B12, pyridoxine/B6) and L-carnitine. It is commonly offered at wellness clinics and compounding pharmacies as a 'fat-burning' injection, though the individual components have limited clinical evidence supporting meaningful weight loss when combined in this formulation. Methionine is an essential amino acid involved in methylation and glutathione synthesis; inositol participates in insulin signaling and lipid metabolism; and choline is required for VLDL assembly and hepatic fat export. While each component has established biochemical roles in lipid metabolism, no large randomized controlled trial has demonstrated that the LIPO-C combination produces clinically significant fat loss beyond what would be expected from diet and exercise alone. The most commonly cited rationale is that these lipotropic factors support hepatic fat processing and methylation pathways, potentially improving the efficiency of fat metabolism in individuals with suboptimal nutrient status. LIPO-C injections are compounded preparations and are not FDA-approved as a drug product. They are generally well-tolerated, with side effects limited to injection-site discomfort and occasional GI upset from the B-vitamin components.

    Also known as: Lipotropic injection, MIC injection, Fat burner blend

    Why Researchers Study It

    LIPO-C formulations are studied as potential adjuncts to weight management because the individual components (methionine, inositol, choline) have documented roles in hepatic lipid export, mitochondrial function, and methyl-donor cycles. Combined administration is hypothesized to amplify these metabolic effects.

    Proposed Mechanisms

    • Methionine serves as substrate for carnitine synthesis, supporting fatty acid oxidation
    • Inositol improves insulin sensitivity and may reduce hepatic steatosis
    • Choline supports VLDL formation and hepatic fat export
    • B vitamins (pyridoxine, B12, cyanocobalamin) support energy metabolism and detoxification pathways

    Evidence Snapshot

    Low Evidence
    Low
    Medium
    High

    Commonly Discussed Benefits

    Safety & Cautions

    • A compounded blend, not a single pharmaceutical
    • Individual ingredient evidence varies in strength
    • Quality depends on compounding pharmacy standards
    • Should be part of a comprehensive weight management plan

    Comparisons

    See how LIPO-C compares to related peptides:

    Calculator Tools

    Use our research tools to explore dosing and reconstitution data:

    Citations

    1. [1] National Institutes of Health — Choline fact sheet. 2022 PubMed

    Continue Your Research

    Track your research notes and set reminders in the companion app.

    Related Peptides

    AOD-9604

    Medium Evidence

    A modified fragment of human growth hormone studied for fat metabolism without growth-promoting effects.

    5-Amino-1MQ

    Low Evidence

    A small molecule NNMT inhibitor studied for metabolic enhancement and fat cell reduction.